FierceBiotechOriginal article
{"a":[{"_":"Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma's ADC pipeline","$":{"href":"/biotech/novartis-pay-11b-upfront-myricx-expand-adc-pipeline","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Novartis is acquiring UK biotech Myricx Bio for $1.1 billion upfront to expand its antibody-drug conjugate (ADC) pipeline with a novel payload platform.
Importance:7/10
Sentiment:
0.60
acquisitionADCantibody-drug conjugatepipeline expansion
Related Companies
Read the original article
Published by FierceBiotech on July 6, 2026 4:22 AM
